NCT00925808 Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans Status UNKNOWN Phase N/A
NCT00925600 Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Status COMPLETED Phase PHASE3
NCT00923065 Data Collection, Clinical Care and Interventions in CCR, NCI Status ENROLLING_BY_INVITATION Phase N/A
NCT00921141 Assessment of Complications, Quality of Life and Easiness of Use of Implantable Central Venous Access Ports Status COMPLETED Phase N/A
NCT00920257 A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795 Status COMPLETED Phase PHASE1
NCT00920205 Safety Study of MPC-3100 in Cancer Patients Who Have Failed Other Treatments Status COMPLETED Phase PHASE1
NCT00920140 Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias Status COMPLETED Phase PHASE2
NCT00911261 Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain Status COMPLETED Phase PHASE3
NCT00911170 PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study Status COMPLETED Phase PHASE3
NCT00907205 A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00907166 A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients Status TERMINATED Phase PHASE1/PHASE2
NCT00906750 A Study of a Live Intranasal Influenza Vaccine in Children With Cancer Status COMPLETED Phase PHASE1
NCT00904579 Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease Status COMPLETED Phase N/A
NCT00904514 Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial Status TERMINATED Phase N/A
NCT00901264 Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients Status COMPLETED Phase N/A
NCT00900302 OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer Status COMPLETED Phase N/A
NCT00899496 Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants Status COMPLETED Phase N/A